New Results
In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis
Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
doi: https://doi.org/10.1101/228171
Sridharan Brindha
1Loyola College, Nungambakkam, Chennai 600034, Tamil Nadu, India
Jagadish Chandrabose Sundaramurthi
2National Institute for Research in Tuberculosis (ICMR), Chetpet, Chennai 600031, Tamil Nadu, India
Savariar Vincent
1Loyola College, Nungambakkam, Chennai 600034, Tamil Nadu, India
Devadasan Velmurugan
3CAS in Crystallography and Biophysics, University of Madras, Guindy Campus, Chennai – 600025, Tamil Nadu, India
John Joel Gnanadoss
1Loyola College, Nungambakkam, Chennai 600034, Tamil Nadu, India

Article usage
Posted December 03, 2017.
In silico and in vitro screening of FDA-approved drugs for potential repurposing against tuberculosis
Sridharan Brindha, Jagadish Chandrabose Sundaramurthi, Savariar Vincent, Devadasan Velmurugan, John Joel Gnanadoss
bioRxiv 228171; doi: https://doi.org/10.1101/228171
Subject Area
Subject Areas
- Biochemistry (10802)
- Bioengineering (8046)
- Bioinformatics (27314)
- Biophysics (13987)
- Cancer Biology (11130)
- Cell Biology (16062)
- Clinical Trials (138)
- Developmental Biology (8788)
- Ecology (13298)
- Epidemiology (2067)
- Evolutionary Biology (17364)
- Genetics (11689)
- Genomics (15926)
- Immunology (11034)
- Microbiology (26114)
- Molecular Biology (10655)
- Neuroscience (56596)
- Paleontology (418)
- Pathology (1733)
- Pharmacology and Toxicology (3005)
- Physiology (4551)
- Plant Biology (9644)
- Synthetic Biology (2690)
- Systems Biology (6979)
- Zoology (1510)